359 related articles for article (PubMed ID: 30761123)
1. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
2. [Interferon-α mediating the functional damage of CD56
Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
[TBL] [Abstract][Full Text] [Related]
3. NK cells and the profile of inflammatory cytokines in the peripheral blood of patients with advanced carcinomas.
Saito LM; Ortiz RC; Amôr NG; Lopes NM; Buzo RF; Garlet GP; Rodini CO
Cytokine; 2024 Feb; 174():156455. PubMed ID: 38043142
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer.
Darvishvand R; Rezaeifard S; Kiani R; Tahmasebi S; Faghih Z; Erfani N
Immun Inflamm Dis; 2024 Apr; 12(4):e1255. PubMed ID: 38652012
[TBL] [Abstract][Full Text] [Related]
5. Functional TRPA1 Channels Regulate CD56
Scopelliti F; Dimartino V; Cattani C; Cavani A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834182
[TBL] [Abstract][Full Text] [Related]
6. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.
Lima M; Almeida J; Montero AG; Teixeira Mdos A; Queirós ML; Santos AH; Balanzategui A; Estevinho A; Algueró Mdel C; Barcena P; Fonseca S; Amorim ML; Cabeda JM; Pinho L; Gonzalez M; San Miguel J; Justiça B; Orfão A
Am J Pathol; 2004 Oct; 165(4):1117-27. PubMed ID: 15466379
[TBL] [Abstract][Full Text] [Related]
7. H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.
Izawa S; Kono K; Mimura K; Kawaguchi Y; Watanabe M; Maruyama T; Fujii H
Cancer Immunol Immunother; 2011 Dec; 60(12):1801-10. PubMed ID: 21811786
[TBL] [Abstract][Full Text] [Related]
8. Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing.
Belounis A; Ayoub M; Cordeiro P; Lemieux W; Teira P; Haddad E; Herblot S; Duval M
Cancer Immunol Immunother; 2020 Sep; 69(9):1767-1779. PubMed ID: 32342128
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
[TBL] [Abstract][Full Text] [Related]
10. Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.
Dowell AC; Oldham KA; Bhatt RI; Lee SP; Searle PF
Cancer Immunol Immunother; 2012 May; 61(5):615-28. PubMed ID: 22021067
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.
Lehmann D; Spanholtz J; Osl M; Tordoir M; Lipnik K; Bilban M; Schlechta B; Dolstra H; Hofer E
Stem Cells Dev; 2012 Nov; 21(16):2926-38. PubMed ID: 22571679
[TBL] [Abstract][Full Text] [Related]
12. Impaired natural killer cell subset phenotypes in human obesity.
Bähr I; Jahn J; Zipprich A; Pahlow I; Spielmann J; Kielstein H
Immunol Res; 2018 Apr; 66(2):234-244. PubMed ID: 29560551
[TBL] [Abstract][Full Text] [Related]
13. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
[TBL] [Abstract][Full Text] [Related]
14. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.
Azeredo EL; De Oliveira-Pinto LM; Zagne SM; Cerqueira DI; Nogueira RM; Kubelka CF
Clin Exp Immunol; 2006 Feb; 143(2):345-56. PubMed ID: 16412060
[TBL] [Abstract][Full Text] [Related]
15. A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection.
Rallón N; Jiménez-Carretero D; Restrepo C; Ligos JM; Valentín-Quiroga J; Mahillo I; Cabello A; López-Collazo E; Sánchez-Cabo F; Górgolas M; Estrada V; Benito JM;
J Med Virol; 2024 May; 96(5):e29646. PubMed ID: 38699988
[TBL] [Abstract][Full Text] [Related]
16. Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection.
Kildey K; Francis RS; Hultin S; Harfield M; Giuliani K; Law BMP; Wang X; See EJ; John G; Ungerer J; Wilkinson R; Kassianos AJ; Healy H
Front Immunol; 2019; 10():1877. PubMed ID: 31440252
[No Abstract] [Full Text] [Related]
17. IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential.
Lehmann D; Spanholtz J; Sturtzel C; Tordoir M; Schlechta B; Groenewegen D; Hofer E
PLoS One; 2014; 9(1):e87131. PubMed ID: 24498025
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.
Ferlazzo G; Pack M; Thomas D; Paludan C; Schmid D; Strowig T; Bougras G; Muller WA; Moretta L; Münz C
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16606-11. PubMed ID: 15536127
[TBL] [Abstract][Full Text] [Related]
19. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
Jewett A; Teruel A; Romero M; Head C; Cacalano N
Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
[TBL] [Abstract][Full Text] [Related]
20. Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions.
Capuano C; De Federicis D; Ciuti D; Turriziani O; Angeloni A; Anastasi E; Giannini G; Belardinilli F; Molfetta R; Alvaro D; Palmieri G; Galandrini R
Front Immunol; 2023; 14():1285203. PubMed ID: 38045702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
